Chidamide Plus R-CHOP Approved in China for MYC/BCL2–Expressing DLBCL

Chidamide plus R-CHOP has received approval from China’s NMPA for the management of diffuse large B-cell lymphoma.

Related Keywords

Japan ,Taiwan ,China ,Chipscreen Biosciences ,Xianping Lu ,China National Medical Products Administration ,Lymphoma International Prognosis Index ,Data Monitoring Committee ,National Medical Products Administration ,Independent Data Monitoring Committee ,Lugano Classification ,Diffuse Largeb Cell Lymphoma ,Chidamide ,R Chop ,